Deka Bank Deutsche Girozentrale Myriad Genetics Inc Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Myriad Genetics Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 35,272 shares of MYGN stock, worth $484,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,272

Previous 35,272 -0.0%

Holding current value

$484,637

Previous $855,000 8.65%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$17.59 - $23.59 $52,418 - $70,298	2,980 Added 9.23%	35,272 $751,000
Q3 2023 Nov 13, 2023	BUY	$15.99 - $23.22 $67,030 - $97,338	4,192 Added 14.92%	32,292 $540,000
Q1 2022 Apr 28, 2022	BUY	$22.67 - $28.01 $58,942 - $72,826	2,600 Added 10.2%	28,100 $717,000
Q4 2021 Feb 02, 2022	BUY	$24.13 - $32.63 $16,891 - $22,841	700 Added 2.82%	25,500 $701,000
Q4 2020 Mar 12, 2021	SELL	$12.16 - $19.77 $14,592 - $23,724	-1,200 Reduced 4.62%	24,800 $449,000
Q3 2020 Oct 29, 2020	BUY	$11.25 - $14.75 $292,500 - $383,500	26,000 New	26,000 $324,000
Q4 2019 Feb 04, 2020	SELL	$20.93 - $35.1 $560,924 - $940,680	-26,800 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $238,463 - $508,464	-10,800 Reduced 28.72%	26,800 $763,000
Q2 2019 Aug 01, 2019	BUY	$22.67 - $35.0 $333,249 - $514,500	14,700 Added 64.19%	37,600 $1.01 Million
Q1 2019 May 10, 2019	BUY	$26.93 - $34.7 $110,413 - $142,270	4,100 Added 21.81%	22,900 $1.14 Million
Q4 2018 Feb 12, 2019	SELL	$27.23 - $45.56 $111,643 - $186,796	-4,100 Reduced 17.9%	18,800 $535,000
Q3 2018 Nov 09, 2018	SELL	$37.57 - $50.34 $22,542 - $30,204	-600 Reduced 2.55%	22,900 $0
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $434,315 - $628,700	-15,651 Reduced 39.98%	23,500 $873,000
Q1 2018 May 03, 2018	SELL	$28.83 - $41.01 $191,488 - $272,388	-6,642 Reduced 14.5%	39,151 $1.16 Million
Q3 2017 Nov 06, 2017	BUY	$24.01 - $36.2 $1.1 Million - $1.66 Million	45,793	45,793 $1.28 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Myriad Genetics Inc Transaction History